Verve Therapeutics
VERV
#6798
Rank
$0.48 B
Marketcap
$5.74
Share price
11.24%
Change (1 day)
-59.83%
Change (1 year)

Verve Therapeutics (VERV) - Total debt

Total debt on the balance sheet as of September 2024 : $71.25 Million USD

According to Verve Therapeutics's latest financial reports the company's total debt is $71.25 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Verve Therapeutics - Total debt on balance sheet (from 2020 to 2024)

Total debt by year

Year Total debt Change
2023-12-31$74.9 M-8.56%
2022-12-31$81.91 M4090.18%
2021-12-31$1.95 M
2020-12-31N/A